Physician profile
Douglas A Bies
NPI 1902881436
$1,483.19
in general payments reported to CMS, 2019-2025
19 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $67.46 · 2021: $196 · 2022: $404 · 2023: $212 · 2024: $223 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $297.70 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $294.07 | 2019-2024 | Dyanavel Xr |
| Corium, LLC | $154.45 | 2021-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $113.97 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $88.42 | 2022-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Glaxosmithkline, LLC. | $86.29 | 2019-2023 | Bexsero |
| Sanofi Pasteur INC. | $83.97 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $77.90 | 2025 | Jornay Pm |
| Seqirus USA INC | $61.57 | 2021-2025 | Fluad, Flucelvax, Flucelvax Quadrivalent |
| Supernus Pharmaceuticals, INC. | $51.44 | 2021-2022 | |
| Pfizer INC. | $40.06 | 2019-2022 | |
| Sobi, INC | $27.71 | 2019-2021 | |
| Verrica Pharmaceuticals INC. | $22.21 | 2025 | Ycanth |
| Cranial Technologies, INC | $16.47 | 2023 | Doc Band |
| Shire North American Group INC | $14.88 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $14.42 | 2024 | Relexxii |
| Sanofi-Aventis U.S. LLC | $13.29 | 2024 | |
| Sarepta Therapeutics, INC. | $12.85 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Bies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.